[Breast cancer: personalised care].
Département d'oncologie médicale, Institut Curie, 75248 Paris 05. pierre.pouillart@curie.net
Pierre
P
Pouillart
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy*; D003657:Decision Making; D005260:Female; D006801:Humans; D008408:Mastectomy; D015412:Mastectomy, Segmental; D020360:Neoadjuvant Therapy; D010347:Patient Care Planning; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000187:drug effects; D021701:Sentinel Lymph Node Biopsy; D043823:Taxoids / Q000627:therapeutic use; D000068878:Trastuzumab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D043823:Taxoids; D000068878:Trastuzumab